Skip to main content
. Author manuscript; available in PMC: 2014 Jun 11.
Published in final edited form as: Clin Genet. 2012 May 1;83(1):35–43. doi: 10.1111/j.1399-0004.2012.01879.x

Table 1.

Clinical diagnosis of patients with DSDa

Identification Clinical diagnosis Genetic diagnosis known
(Y/N)
Genetic diagnosis
identified by targeted
sequencing (Y/N)
46, XY male Control XY male
46, XX female Control XX female
47, XXY KS Klinefelter syndrome Y Y
45, XO TS Turner syndrome Y Y
DSDPt1 5-Alpha reductase deficiency N Y (SRD5A2, E200K)
DSDPt2 46, XY gonadal dysgenesis Y [NROB1 (DAX1) duplication] Y
DSDPt3 46, XY gonadal dysgenesis Y (SRY, Y127C) Y
DSDPt4 46, XY gonadal dysgenesis + campomelic
 dysplasia
N N
DSDPt5 46, XY gonadal dysgenesis + galactosemia N N
DSDPt6 46, XX testicular DSD N N
DSDPt7 46, XY DSD Y (AR, M788T) Y
DSDPt8 46, XY female + AHC Y (DAX1, Y121*) Y
DSDPt9 46, XY DSD severe combined adrenal and
 gonadal deficiency
Y (CYP11A1) Y
DSDPt10 46, XX testicular DSD N N
DSDPt11 46, XY gonadal dysgenesis N N
DSDPt12 46, XY gonadal dysgenesis N Y (ATRX, K1045E)

AHC, adrenal hypoplasia congenita; DSD, disorders of sex development; N, no; Y, yes.

a

All patients in this study were clinically diagnosed with a DSD.